血管紧张素受体阻滞剂对高血压 2 型糖尿病患者动脉僵硬度的影响。
The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension.
机构信息
Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
出版信息
Diabetes Metab J. 2011 Jun;35(3):236-42. doi: 10.4093/dmj.2011.35.3.236. Epub 2011 Jun 30.
Abstract
BACKGROUND
Hypertension and type 2 diabetes mellitus are major risk factors for cardiovascular disease. This study analyzed the changes in central aortic waveforms and pulse wave velocity as well as related parameters after treatment with valsartan, an angiotensin II type 1 receptor blocker, in patients with type 2 diabetes and hypertension.
METHODS
We used pulse wave analysis to measure central aortic waveform in a total of 98 subjects. In 47 of these patients, pulse wave velocity measurements were obtained before and after 12 weeks of treatment with valsartan.
RESULTS
In the central aortic waveform analysis, the aortic pulse pressure and augmentation index were significantly decreased after valsartan treatment, as was the aortic pulse wave velocity. Factors contributing to the improvement in pulse wave velocity were the fasting blood glucose and haemoglobin A1c levels.
CONCLUSION
Short-term treatment with valsartan improves arterial stiffness in patients with type 2 diabetes and hypertension, and the glucose status at baseline was associated with this effect.
摘要
背景
高血压和 2 型糖尿病是心血管疾病的主要危险因素。本研究分析了血管紧张素 II 型 1 型受体阻滞剂缬沙坦治疗 2 型糖尿病合并高血压患者后中心主动脉波形和脉搏波速度及相关参数的变化。
方法
我们使用脉搏波分析测量了 98 例患者的中心主动脉波形。其中 47 例患者在接受缬沙坦治疗 12 周前后进行了脉搏波速度测量。
结果
在中心主动脉波形分析中，主动脉脉搏压和增强指数在缬沙坦治疗后明显降低，主动脉脉搏波速度也降低。与脉搏波速度改善相关的因素是空腹血糖和糖化血红蛋白水平。
结论
短期使用缬沙坦可改善 2 型糖尿病合并高血压患者的动脉僵硬度，且基线时的血糖状况与该效应相关。
相似文献
1
The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension.血管紧张素受体阻滞剂对高血压 2 型糖尿病患者动脉僵硬度的影响。
Diabetes Metab J. 2011 Jun;35(3):236-42. doi: 10.4093/dmj.2011.35.3.236. Epub 2011 Jun 30.
2
Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.在难治性高血压中加用血管紧张素II受体阻滞剂对动脉波反射和脉压放大的有利影响。
J Hum Hypertens. 2000 Sep;14(9):541-6. doi: 10.1038/sj.jhh.1001053.
3
Volume status and arterial blood pressures are associated with arterial stiffness in hemodialysis patients.容量状态和动脉血压与血液透析患者的动脉僵硬度相关。
Int J Artif Organs. 2018 Jul;41(7):378-384. doi: 10.1177/0391398818778212. Epub 2018 May 28.
4
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.缬沙坦可改善2型糖尿病患者的动脉僵硬度，且独立于其降压作用。
Hypertension. 2008 Jun;51(6):1617-23. doi: 10.1161/HYPERTENSIONAHA.108.111674. Epub 2008 Apr 21.
5
An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry.大动脉力学的最新临床入门知识：脉搏波形分析和动脉张力测量法的意义
Curr Opin Cardiol. 2005 Jul;20(4):275-81. doi: 10.1097/01.hco.0000166595.44711.6f.
6
Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.脂蛋白（a）作为老年2型糖尿病患者动脉僵硬度的一个决定因素。
Clin Chim Acta. 2006 Nov;373(1-2):127-31. doi: 10.1016/j.cca.2006.05.018. Epub 2006 May 17.
7
Angiotensin II type 1 receptor blockers prevent aortic arterial stiffness in elderly patients with hypertension.血管紧张素 II 型 1 型受体阻滞剂可预防老年高血压患者的主动脉动脉僵硬度。
Clin Exp Hypertens. 2019;41(7):657-661. doi: 10.1080/10641963.2018.1529781. Epub 2018 Oct 12.
8
Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.缬沙坦阻断血管紧张素II受体对原发性高血压患者颈动脉僵硬度和血流动力学改变的长期影响。
Clin Exp Hypertens. 2008 Jul;30(5):415-22. doi: 10.1080/10641960802279108.
9
Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.沙库巴曲缬沙坦与奥美沙坦对老年收缩期高血压患者中心血流动力学的影响：PARAMETER研究
Hypertension. 2017 Mar;69(3):411-420. doi: 10.1161/HYPERTENSIONAHA.116.08556. Epub 2017 Jan 16.
10
Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.从无创压力波形获得的动脉僵硬度的临床测量。
Am J Hypertens. 2005 Jan;18(1 Pt 2):3S-10S. doi: 10.1016/j.amjhyper.2004.10.009.
引用本文的文献
1
The Value of Serial Measurement of Arterial Stiffness in Cardiovascular Disease.动脉僵硬度连续测量在心血管疾病中的价值
Rev Cardiovasc Med. 2024 Jan 8;25(1):7. doi: 10.31083/j.rcm2501007. eCollection 2024 Jan.
2
Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial.恩格列净、氯沙坦及其联合治疗 2 型糖尿病患者的降压作用机制：一项随机交叉试验的二次分析。
Diabetes Obes Metab. 2023 Jan;25(1):198-207. doi: 10.1111/dom.14864. Epub 2022 Sep 27.
3
The impact of angiotensin receptor blockers on arterial stiffness: a meta-analysis.血管紧张素受体阻滞剂对动脉僵硬度的影响：一项荟萃分析。
Hypertens Res. 2015 Sep;38(9):613-20. doi: 10.1038/hr.2015.51. Epub 2015 Apr 9.
4
Functional vascular study in hypertensive subjects with type 2 diabetes using losartan or amlodipine.使用氯沙坦或氨氯地平对2型糖尿病高血压患者进行的功能性血管研究。
Arq Bras Cardiol. 2014 Jul;103(1):51-9. doi: 10.5935/abc.20140089. Epub 2014 Jul 9.
5
Letter: the effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension (diabetes metab j 2011;35:236-42).信函：血管紧张素受体阻滞剂对2型糖尿病合并高血压患者动脉僵硬度的影响（《糖尿病与代谢杂志》2011年；35：236 - 42）
Diabetes Metab J. 2011 Aug;35(4):427-8. doi: 10.4093/dmj.2011.35.4.427. Epub 2011 Aug 31.
本文引用的文献
1
Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.缬沙坦阻断血管紧张素II受体对原发性高血压患者颈动脉僵硬度和血流动力学改变的长期影响。
Clin Exp Hypertens. 2008 Jul;30(5):415-22. doi: 10.1080/10641960802279108.
2
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.缬沙坦可改善2型糖尿病患者的动脉僵硬度，且独立于其降压作用。
Hypertension. 2008 Jun;51(6):1617-23. doi: 10.1161/HYPERTENSIONAHA.108.111674. Epub 2008 Apr 21.
3
Subendocardial viability ratio estimated by arterial tonometry: a critical evaluation in elderly hypertensive patients with increased aortic stiffness.通过动脉张力测量法估算的心内膜下存活比率：对主动脉僵硬度增加的老年高血压患者的关键评估
Clin Exp Pharmacol Physiol. 2008 Aug;35(8):909-15. doi: 10.1111/j.1440-1681.2008.04927.x. Epub 2008 Mar 13.
4
Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives.糖尿病高血压患者长期使用血管紧张素转换酶抑制剂后，肱动脉血压独立降低颈动脉僵硬度。
Hypertension. 2006 Jul;48(1):80-6. doi: 10.1161/01.HYP.0000224283.76347.8c. Epub 2006 May 15.
5
Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population.主动脉脉搏波速度作为一般人群动脉僵硬度指标的预后价值。
Circulation. 2006 Feb 7;113(5):664-70. doi: 10.1161/CIRCULATIONAHA.105.579342.
6
Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus.
Clin Chim Acta. 2006 Mar;365(1-2):230-5. doi: 10.1016/j.cca.2005.08.023. Epub 2005 Sep 29.
7
Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension.血管紧张素II受体阻滞剂可预防原发性高血压患者动脉僵硬度增加。
Circ J. 2004 Dec;68(12):1194-8. doi: 10.1253/circj.68.1194.
8
Effects of coexisting hypertension and type II diabetes mellitus on arterial stiffness.高血压与2型糖尿病并存对动脉僵硬度的影响。
J Hum Hypertens. 2004 Jul;18(7):469-73. doi: 10.1038/sj.jhh.1001690.
9
Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?高血压性心肌纤维化与舒张功能障碍：另一种炎症模型？
Hypertension. 2004 Apr;43(4):739-45. doi: 10.1161/01.HYP.0000118584.33350.7d. Epub 2004 Feb 16.
10
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.糖尿病与血管疾病：病理生理学、临床后果及药物治疗：第一部分
Circulation. 2003 Sep 23;108(12):1527-32. doi: 10.1161/01.CIR.0000091257.27563.32.
Zotero 插件